Stability of dendriplexes formed by anti-HIV genetic material and poly(propylene imine) dendrimers in the presence of glucosaminoglycans

Journal of Physical Chemistry B

Volumn 116, Issue 50, 2012, Pages 14525-14532

  Szewczyk, Michal ^a   Drzewinska, Joanna ^a   Dzmitruk, Volha ^b   Shcharbin, Dzmitry ^b   Klajnert, Barbara ^a   Appelhans, Dietmar ^c   Bryszewska, Maria ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b INSTITUTE OF PHOTOBIOLOGY   (Belarus)

^c LEIBNIZ INSTITUTE OF POLYMER RESEARCH DRESDEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-HIV; ANTISENSE OLIGODEOXYNUCLEOTIDES; CHONDROITIN SULFATES; DENDRIPLEXES; EXTRACELLULAR MATRIX COMPONENTS; FLUORESCENCE POLARIZATION; FOURTH GENERATION; GEL ELECTROPHORESIS; GENETIC MATERIALS; GLUCOSAMINOGLYCANS; GLYCODENDRIMERS; HEPARAN SULFATES; HYALURONIC ACIDS; MALTOTRIOSE; OPEN-SHELL; PHYSIOLOGICAL CONCENTRATIONS; POLY (PROPYLENE IMINE) DENDRIMERS; SURFACE GROUPS; TRANSFECTION ACTIVITY;

DENDRIMERS; ELECTROPHORESIS; NITROGEN COMPOUNDS; OLIGOSACCHARIDES; ORGANIC ACIDS; PHYSIOLOGY; POLYSACCHARIDES; TISSUE;

PROPYLENE;

ANTISENSE OLIGONUCLEOTIDE; DENDRIMER; GLUCOSAMINOGLYCANS; GLYCOSAMINOGLYCAN; POLYPROPYLENE; POLYPROPYLENEIMINE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; DRUG STABILITY; ELECTROPHORESIS; FLUORESCENCE POLARIZATION; GENE THERAPY; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; NUCLEOTIDE SEQUENCE; PARTICLE SIZE;

BASE SEQUENCE; DENDRIMERS; DRUG STABILITY; ELECTROPHORESIS; FLUORESCENCE POLARIZATION; GENETIC THERAPY; GLYCOSAMINOGLYCANS; HIV-1; MODELS, MOLECULAR; MOLECULAR CONFORMATION; OLIGONUCLEOTIDES, ANTISENSE; PARTICLE SIZE; POLYPROPYLENES;

EID: 84871598363     PISSN: 15206106     EISSN: 15205207     Source Type: Journal    
DOI: 10.1021/jp304449v     Document Type: Article

References (52)

1. Itaka, K.; Kataoka, K. Eur. J. Pharm. Biopharm. 2009, 71, 475-483
2. Aigner, A. Curr. Pharm. Res. 2008, 14, 3603-3619
3. Dufes, C.; Uchegbu, I. F.; Schatzlein, A. G. Adv. Drug Delivery Rev. 2005, 57, 2177-2202
4. Shcharbin, D. G.; Klajnert, B.; Bryszewska, M. Biochemistry 2009, 74, 1070-1079
5. Shakhbazau, A.; Isayenka, I.; Kartel, N.; Goncharova, N.; Seviaryn, I.; Kosmacheva, S.; Potapnev, M.; Shcharbin, D.; Bryszewska, M. Int. J. Pharm. 2010, 383, 228-235
6. Shakhbazau, A.; Shcharbin, D.; Seviaryn, I.; Goncharova, N.; Kosmacheva, S.; Potapnev, M.; Bryszewska, M.; Kumar, R.; Biernaskie, J.; Midha, R. Mol. Pharmaceutics 2012, 9, 1521-1528
7. Shakhbazau, A.; Shcharbin, D.; Petyovka, N.; Goncharova, N.; Seviaryn, I.; Kosmacheva, S.; Bryszewska, M.; Potapnev, M. J. Pharm. Sci. 2012, 101, 1546-1554
8. Shakhbazau, A.; Shcharbin, D.; Bryszewska, M.; Biernaskie, J.; Kumar, R.; Kallos, M. S.; Goncharova, N.; Seviaryn, I.; Kosmacheva, S.; Potapnev, M. Curr. Med. Chem. 2012, http://www.ncbi.nlm.nih.gov/pubmed/22834817
9. Zinselmeyer, B. H.; Mackay, S. P.; Schatzlein, A. G.; Uchegbu, I. F. Pharm. Res. 2002, 19, 960-967
10. Santhakumaran, L. M.; Thomas, T.; Thomas, T. J. Nucleic Acids Res. 2004, 32, 2102-2112
11. Haensler, J.; Szoka, F. C., Jr. Bioconjugate Chem. 1993, 4, 372-379
12. Sonawane, N. D.; Szoka, F. C.; Verkman, A. S. J. Biol. Chem. 2003, 278, 44826-44831
13. Malik, N.; Wiwattanapatapee, R.; Klopsch, R.; Lorenz, K.; Frey, H.; Weener, J. W.; Meijer, E. W.; Paulus, W.; Duncan, R. J. Controlled Release 2000, 65, 133-148
14. Ziemba, B.; Janaszewska, A.; Ciepluch, K.; Krotewicz, M.; Fogel, W. A.; Appelhans, D.; Voit, B.; Bryszewska, M.; Klajnert, B. J. Biomed. Mater. Res., Part A 2011, 99, 261-268
15. Agashe, H. B.; Dutta, T.; Garg, M.; Jain, N. K. J. Pharm. Pharmacol. 2006, 58, 1491-1498
16. Klajnert, B.; Appelhans, D.; Komber, H.; Morgner, N.; Schwarz, S.; Richter, S.; Brutschy, B.; Ionov, M.; Tonkikh, A. K.; Bryszewska, M. Chemistry 2008, 14, 7030-7041
17. Fischer, M.; Appelhans, D.; Klajnert, B.; Bryszewska, M.; Voit, B.; Rogers, M. Biomacromolecules 2010, 11, 1314-1325
18. Klementieva, O.; Benseny-Cases, N.; Gella, A.; Appelhans, D.; Voit, B.; Cladera, J. Biomacromolecules 2011, 12, 3903-3909
19. Höbel, S.; Loos, A.; Appelhans, D.; Schwarz, S.; Seidel, J.; Voit, B.; Aigner, A. J. Controlled Release 2011, 149, 146-158
20. Janaszewska, A.; Maczynska, K.; Matuszko, G.; Appelhans, D.; Voit, B.; Klajnert, B.; Bryszewska, M. New J. Chem. 2012, 36, 428-437
21. Fischer, M.; Appelhans, D.; Klajnert, B.; Bryszewska, M.; Voit, B.; Rogers, M. Biomacromolecules 2010, 11, 1314-1325
22. Köth, A.; Appelhans, D.; Tiersch, B.; Koetz, J. Soft Matter 2011, 7, 10581-10584
23. Bordier, B.; Helene, C.; Barr, P. J.; Litvak, S.; Sarih-Cottin, L. Nucleic Acids Res. 1992, 20, 5999-6006
24. Yamaguchi, K.; Papp, B.; Zhang, D.; Ali, A. N.; Agrawal, S.; Byrn, R. A. AIDS Res. Hum. Retroviruses 1997, 13, 545-554
25. Lavigne, C.; Yelle, J.; Sauve, G.; Thierry, A. R. AAPS Pharm. Sci. 2001, 3, E7
26. Pedziwiatr-Werbicka, E.; Ferenc, M.; Zaborski, M.; Gabara, B.; Klajnert, B.; Bryszewska, M. Colloids Surf., B 2011, 83, 360-366
27. Egilmez, N. K.; Iwanuma, Y.; Bankert, R. B. Biochem. Biophys. Res. Commun. 1996, 221, 169-173
28. Shcharbin, D.; Pedziwiatr, E.; Chonco, L.; Bermejo-Martín, J. F.; Ortega, P.; de la Mata, F. J.; Eritja, R.; Gómez, R.; Klajnert, B.; Bryszewska, M. Biomacromolecules 2007, 8, 2059-2062
29. Chonco, L.; Bermejo-Martín, J. F.; Ortega, P.; Shcharbin, D.; Pedziwiatr, E.; Klajnert, B.; de la Mata, F. J.; Eritja, R.; Gómez, R.; Bryszewska, M. Org. Biomol. Chem. 2007, 5, 1886-1893
30. Ruponen, M.; Honkakoski, P.; Rönkkö, S.; Pelkonen, J.; Tammi, M.; Urtti, A. J. Controlled Release 2003, 93, 213-217
31. Pitkänen, L.; Ruponen, M.; Nieminen, J.; Urtti, A. Pharm. Res. 2003, 20, 576-583
32. Mislick, K. A.; Baldeschwieler, J. D. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 12349-12354
33. Ruponen, M.; Ylä-Herttuala, S.; Urtti, A. Biochim. Biophys. Acta 1999, 1415, 331-341
34. Ruponen, M.; Rönkkö, S.; Honkakoski, P.; Pelkonen, J.; Tammi, M.; Urtti, A. J. Biol. Chem. 2001, 276, 33875-33880
35. Ciolkowski, M.; Palecz, B.; Appelhans, D.; Voit, B.; Klajnert, B.; Bryszewska, M. Colloids Surf., B 2012, 95, 103-108
36. Mkandawire, M.; Pohl, A.; Gubarevich, T.; Lapina, V.; Appelhans, D.; Rödel, G.; Pompe, W.; Schreiber, J.; Opitz, J. J. Biophotonics 2009, 2, 596-606
37. Garg, H.; Linhardt, R.; Hales, C. Chemistry and Biology of Heparin and Heparan Sulfate; Elsevier: Amsterdam, The Netherlands, 2005.
38. Heuck, C. C.; Schiele, U.; Horn, D.; Fronda, D.; Ritz, E. J. Biol. Chem. 1985, 260, 4598-4603
39. Maly, J.; Pedziwiatr-Werbicka, E.; Maly, M.; Semeradtova, A.; Appelhans, D.; Danani, A.; Zaborski, M.; Klajnert, B.; Bryszewska, M. Curr. Med. Chem. 2012, 19, 4708-4719
40. Shcharbin, D.; Pedziwiatr, E.; Bryszewska, M. J. Controlled Release 2009, 135, 186-197
41. Pedziwiatr, E.; Shcharbin, D.; Bryszewska, M.; Maly, J.; Maly, M.; Zaborski, M.; Gabara, B.; Ortega, P.; de la Mata, F. J.; Gómez, R. J. Biomed. Nanotechnol. 2012, 8, 57-73
42. Engelberg, H.; Dudley, A. Circulation 1961, 23, 578-581
43. Schwalbe, R. A.; Dahlbäck, B.; Nelsestuen, G. L. J. Biol. Chem. 1991, 266, 12896-12901
44. Staprans, I.; Felts, J. M. J. Clin. Invest. 1985, 76, 1984-1991
45. Gallagher, J. T.; Lyon, M. In Proteoglycans: Structure, Biology and Molecular Interactions; Iozzo, M.V., Ed.; Marcel Dekker Inc.: New York, 2000; pp 27-59.
46. Fraser, J. R.; Laurent, T. C.; Laurent, U. B. J. Int. Med. 1997, 242, 27-33
47. Sabaratnam, S.; Coleman, P. J.; Badrick, E.; Mason, R. M.; Levick, J. R. J. Physiol. 2002, 540, 271-284
48. Zinellu, E.; Lepedda, A.; Cigliano, A.; Pisanu, S.; Zinellu, A.; Carru, C.; Bacciu, P. P.; Piredda, F.; Guarino, A.; Spirito, R. Biochem. Res. Int. 2012, 281284
49. Kaszuba, M. Zetasizer Nano Series: Dynamic Light Scattering and Zetasizer Nano Series: Zeta Potential. Malvern Presentations. http://www.malvern.com/ labeng/education/elearning/elearning-courses.htm (accessed June 2010).
50. An Introduction To Particle Size. Malvern On-Demand Presentation. http://www.malvern.com/malvern/ondemand.nsf/id/RGUE-8FN37A (accessed October 2012).
51. An Introduction To The Links Between Rheology And Particle Size. Malvern On-Demand Presentation. http://www.malvern.com/malvern/ondemand.nsf/id/JDUY- 7VWRLK (accessed October 2012).
52. Nanoparticle Characterization: Size, Charge and Heterogeneity. Malvern On-Demand Presentation. http://www.malvern.com/malvern/ondemand.nsf/id/591914156 (accessed October 2012).